We use cookies to improve your browsing experience.
And cake to boost morale on Fridays. Find out more about our cookie policy here.
Uh oh! Looks like your browser’s out of date.
You’ll have more fun viewing our site on one of these instead.

The Challenge

Design an over-the-counter, drug-free alternative wearable device for chronic pain sufferers.

The Outcome

A first-of-its-kind device called Quell, an FDA-approved wearable that provides 100 percent drug-free, widespread relief from chronic pain.

Quell Quell Man Walking

Quell stimulates the sensory nerves, triggering the body’s natural pain-relief response and blocking pain signals in the body.

Chronic pain changes everything. Symptoms associated with chronic conditions can make activities that were a normal part of life—getting regular exercise or even a good night’s sleep—difficult to bear.

NeuroMetrix, an innovative health-care company based in Waltham, Massachusetts, developed Quell® to help treat chronic pain in people suffering from nerve, arthritic, back, leg, and foot conditions. Using a revolutionary technology called wearable intensive nerve stimulation (WINS), this device triggers widespread relief and, in a clinical study, reduced chronic pain and use of medication in the majority of users.

NeuroMetrix came to IDEO to help create the industrial design, interaction design, and mechanical engineering to bring Quell to the consumer market. Quell is a device that is placed in a sports band with a lightweight, slim design that fits comfortably on the upper calf and delivers therapy for chronic pain in the body. Its patented OptiTherapy™ technology is customized and automatically adjusts the therapy dose for optimal relief. An accompanying app, developed by Atomic Object, allows users to track treatment sessions, measure and understand the quality of their sleep as it relates to their pain, and personalize device settings.

IDEO’s work with Quell went beyond creating the product to something bigger—reframing chronic pain. For people who are in a constant state of suffering, the ability to take some measure of control allows them to feel more like active participants in their treatment plan, and to regain confidence.

Quell has been cleared by the FDA for 24/7 use and is currently available for sale.

IDEO’s expertise in leveraging consumer insights around our neurotechnology and application to pain relief translated into a lightweight, high tech product design that seamlessly fit into our end users’ lives.

Shai Gozani, M.D., Ph.D., and President/CEO of NeuroMetrix